Therapy reduces early menopause for women with breast cancer

Therapy appears to reduce rate of chemotherapy-induced early menopause for women with breast cancer – Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July_20 issue of JAMA.

Breastfeeding reduces multiple sclerosis relapse in women

Breastfeeding associated with a reduced risk of relapse in women with multiple sclerosis – Women with multiple sclerosis who breastfeed exclusively for at least two months appear less likely to experience a relapse within a year after their baby’s birth, according to a report that will appear in the August print issue of Archives of Neurology, one of the JAMA/Archives journals.

Women’s menstruation genes identified

Genes that influence start of menstruation identified for first time – Two genes clarify the genetic control of female sexual maturation, and point to regulatory mechanisms involved in human growth and development. – Researchers from the Peninsula Medical School, along with collaborators from research institutions across Europe and the United States, have for the first time identified two genes that are involved in determining when girls begin menstruation.

Arthritis drug celecoxib can adversely affect heart rhythm

There has been much concern about the possibility of increased risk for heart attack and stroke in users of NSAID drugs, particularly COX-2 selective NSAIDs such as celecoxib. – COX-2 inhibitors like Celecoxib have come under scrutiny lately due to adverse cardiovascular side-effects stemming from COX-2 reduction. In both fruit fly and rat models, researchers reveal another adverse effect of Celecoxib; this drug can induce arrhythmia. More interestingly, this effect is independent of the COX-2 enzyme.